Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs

CPT Pharmacometrics Syst Pharmacol. 2016 Apr;5(4):201-10. doi: 10.1002/psp4.12074. Epub 2016 Apr 14.

Abstract

Pulmonary drug disposition after inhalation is complex involving mechanisms, such as regional drug deposition, dissolution, and mucociliary clearance. This study aimed to develop a systems pharmacology approach to mechanistically describe lung disposition in rats and thereby provide an integrated understanding of the system. When drug- and formulation-specific properties for the poorly soluble drug fluticasone propionate were fed into the model, it proved predictive of the pharmacokinetics and receptor occupancy after intravenous administration and nose-only inhalation. As the model clearly distinguishes among drug-specific, formulation-specific, and system-specific properties, it was possible to identify key determinants of pulmonary selectivity of receptor occupancy of inhaled drugs: slow particle dissolution and slow drug-receptor dissociation. Hence, it enables assessment of factors for lung targeting, including molecular properties, formulation, as well as the physiology of the animal species, thereby providing a general framework for rational drug design and facilitated translation of lung targeting from animal to man.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Animals
  • Biological Availability
  • Bronchodilator Agents / administration & dosage*
  • Bronchodilator Agents / blood
  • Bronchodilator Agents / pharmacokinetics*
  • Chemistry, Pharmaceutical
  • Fluticasone / administration & dosage*
  • Fluticasone / blood
  • Fluticasone / pharmacokinetics*
  • Humans
  • Lung / metabolism*
  • Models, Animal
  • Models, Biological
  • Rats
  • Receptors, Glucocorticoid / metabolism*

Substances

  • Bronchodilator Agents
  • Receptors, Glucocorticoid
  • Fluticasone